Ibaraki, Japan

Ayako Moritomo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Ibaraki, JP (2009 - 2010)
  • Tokyo, JP (2011 - 2016)

Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Ayako Moritomo

Introduction

Ayako Moritomo is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of potassium ion channel modulation, with a focus on developing novel compounds that can be utilized in therapeutic and diagnostic methods. Her work has led to the filing of two patents, showcasing her innovative approach to scientific challenges.

Latest Patents

Ayako Moritomo's latest patents include "Polycyclic pyrazines as potassium ion channel modulators" and "Polycyclic pyrimidines as potassium ion channel modulators." The first patent presents a genus of polycyclic pyrazines that are designed to modulate potassium ion channels, which are crucial for various physiological processes. The second patent focuses on polycyclic pyrimidines that also serve as modulators of potassium ion channels, further emphasizing their potential in therapeutic applications.

Career Highlights

Ayako Moritomo is currently associated with Icagen, Inc., where she continues to advance her research in the field of ion channel modulation. Her work is characterized by a commitment to innovation and a deep understanding of the underlying scientific principles.

Collaborations

Throughout her career, Ayako has collaborated with esteemed colleagues, including Xiaodong Wang and Kerry Leigh Spear. These collaborations have enriched her research and contributed to the development of her patented inventions.

Conclusion

Ayako Moritomo's contributions to the field of potassium ion channel modulation highlight her innovative spirit and dedication to scientific advancement. Her patents reflect her ability to address complex challenges in therapeutic and diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…